Juvenile Myopia
11
4
10
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (11)
Control of Myopia Using Novel Spectacle Lens Designs
Myopia Control Spectacle Lens Cessation Study
Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness
Assessment of DOT Spectacles in Chinese Children
CYPRESS Efficacy and Safety Study Extension
Spectacle Lens Visual Acuity Assessments Study
Children's Viewing Behavior
Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Assessment of DOT Spectacles in Chinese Children Extension
Myopia Assessment of Two Manufacturing Processes